Wantai biology: it is planned to invest in the construction project of Xiamen Wantai diagnosis base

Healthcare, Industrials Jul 06, 2021 06:49 PM (GMT+8) · EqualOcean

Wantai bio announced that its wholly-owned subsidiary Wantai Carey plans to invest in the construction and implementation of "Xiamen Wantai diagnosis base construction project", with an estimated total investment of 1.336 billion yuan. On the same day announcement, the New Coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) produced by the company was approved by the national drug and Health Products Safety Administration (ANSM) recently and can be sold in the French market.

This text is a result of machine translation.

Related companies：

Wantai

Briefing Sep 12, 2023 04:28 PM · Industrials | Automotive

New Energy Vehicle Sales Up 27% in August 2023

Briefing Sep 11, 2023 02:37 PM · Industrials | Automotive

Tesla Announces Global Supercharger Network Surpasses 50,000 Units

In-depth

Mixue Ice Cream & Tea's Listing: Capital Ambitions and Global Quest of a Budget Tea Giant

Mar 27, 2025 05:43 PM

Briefing Feb 21, 2023 11:10 AM · Healthcare

We-Linking Raised Over CNY 10 Mn in Angel Round

Briefing Feb 21, 2023 10:07 AM · Healthcare

Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round

Research

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Digital Transformation of Domestic Construction Industry in 2022

Apr 28, 2022 08:00 PM

Briefing Feb 16, 2023 12:51 PM · Healthcare

Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

Briefing Feb 15, 2023 12:32 PM · Healthcare

ZD Medtech Raised Over CNY 100 Mn in Series B

Briefing Feb 13, 2023 12:54 PM · Healthcare

Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn

Briefing Feb 08, 2023 11:44 AM · Healthcare

Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A

Trump Declares a National Emergency and Imposes Tariffs Across the Board

Apr 03, 2025 04:57 PM

SF Holding Achieves Net Profit of Over CNY 10 Bn in 2024

Apr 01, 2025 05:02 PM

Briefing Feb 07, 2023 12:11 PM · Healthcare

ForLong Biotech Nets Over CNY 100 Mn in Series A

Briefing Feb 07, 2023 10:59 AM · Healthcare

CytoCan Corp. Nets CNY 10 Mn in Seed Round

Briefing Feb 16, 2022 03:19 PM · Technology | Financials

Samsung Electronics union threatened to hold the first strike in the company's 53 year history

Chinese Entrepreneurs Delegation Visits Brazil

Apr 01, 2025 04:39 PM

China's Port Cargo Throughput and Container Throughput Ranked First in the World in 2024

Apr 01, 2025 04:36 PM

Briefing Oct 15, 2021 06:25 PM · Healthcare

Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine

Briefing Sep 02, 2021 02:06 PM · Healthcare

Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%

Briefing Sep 02, 2021 10:22 AM · Healthcare | Financials

The biological vaccine sector weakened, and Watson biology fell more than 6%

Briefing Jul 29, 2021 10:01 AM

Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%

See more